Biotech Week articles from October 2003

Biotech Week archives from October 2003

Researchers describe simple way to reduce HIV transmission from mom to baby.
October 1, 2003... 2003 OCT 1 - (NewsRx.com & NewsRx.net) -- Johns Hopkins and Ugandan researchers reported final results of a study showing that a safe, simple and inexpensive treatment reduces transmission of HIV from mothers to babies during childbirth and the...

Scientists announce vaccine hope.
October 1, 2003... 2003 OCT 1 - (NewsRx.com & NewsRx.net) -- Vaccines could be used alongside conventional treatments to combat certain forms of cancer, scientists suggest. A Cancer Research UK scientist and his team have found that a vaccine targeted...

Companies sign agreement in field of single-chain antibodies and phage display.
October 1, 2003... 2003 OCT 1 - (NewsRx.com & NewsRx.net) -- Cambridge Antibody Technology (CATG), Micromet, AG, and Enzon Pharmaceuticals, Inc., (ENZN) have signed a nonexclusive cross-license agreement, under which all three parties obtain substantial freedom...

Production of recombinant botulinum protein vaccine candidate reported.
October 1, 2003... 2003 OCT 1 - (NewsRx.com & NewsRx.net) -- Researchers have produced a recombinant protein vaccine candidate using the botulinum neurotoxin heavy chain fragment. "Structural conversion of the serotype A recombinant botulinum neurotoxin...

Paxil improves memory and brain structure in PTSD sufferers.
October 1, 2003... 2003 OCT 1 - (NewsRx.com & NewsRx.net) -- Researchers have found that paroxetine HCL (Paxil) produces measurable improvement in verbal memory and also increases the size of the hippocampus, a key area of the brain involved in learning and...

MADIT II compares efficacy of implantable defibrillator in Europe, U.S.
October 1, 2003... 2003 OCT 1 - (NewsRx.com & NewsRx.net) -- Sudden cardiac death from ventricular tachyarrhythmias is the leading cause of death in Europe and the U.S. It affects hundreds of thousands of people each year. Many of them have known heart...

New study aims to prevent heart disease in pediatric patients.
October 1, 2003... 2003 OCT 1 - (NewsRx.com & NewsRx.net) -- Researchers from Duke University Medical Center will study the use of cholesterol-lowering drugs to prevent heart disease in pediatric patients with lupus erythematosus. Atherosclerosis, or...

SSTR5 mutations unlikely to cause autism.
October 1, 2003... 2003 OCT 1 - (NewsRx.com & NewsRx.net) -- SSTR5 mutations do not appear to be responsible for autism development. "Infantile autism is a pervasive developmental disorder with a strong genetic component," researchers in Denmark explained....

Brazil takes first step toward breaking patents on AIDS drugs.
October 1, 2003... 2003 OCT 1 - (NewsRx.com & NewsRx.net) -- Brazil took the first formal step toward breaking patents with three pharmaceutical companies selling AIDS drugs to South America's largest country after talks failed to produce price reductions...

DHHS panel recommends Kaletra as part of protease inhibitor-based regimen.
October 1, 2003... 2003 OCT 1 - (NewsRx.com & NewsRx.net) -- A panel convened by the U.S. Department of Health and Human Services (DHHS) has recommended Kaletra (lopinavir/ritonavir), in combination with zidovudine or stavudine plus lamivudine, as a preferred...

Fall team sports injuries high among adolescents.
October 1, 2003... 2003 OCT 1 - (NewsRx.com & NewsRx.net) -- Football, basketball, indoor volleyball, swimming, cheerleading, gymnastics, and field hockey are just a few of the team sports that will occupy adolescents' time this fall at school. But these...

Patent issued for antitumor agents.
October 1, 2003... 2003 OCT 1 - (NewsRx.com & NewsRx.net) -- The U.S. Patent and Trademark Office (USPTO) issued a patent to Advanced Life Sciences (ALS) for a class of indolocarbazole compounds with a lead molecule, ALS-423, that blocks topoisomerase I, a...

Data from phase III study of Combidex published.
October 1, 2003... 2003 OCT 1 - (NewsRx.com & NewsRx.net) -- Advanced Magnetics, Inc., (AVM) and Cytogen Corporation (CYTO) announced that data from the phase III clinical study of Combidex (ferumoxtran-10) in lymph nodes were published in the September issue of...

Company launches GeneChip CustomExpress 11-micron array format.
October 1, 2003... 2003 OCT 1 - (NewsRx.com & NewsRx.net) -- Affymetrix, Inc., (AFFX) has launched its new GeneChip brand CustomExpress 11-micron array format, which can measure up to 61,000 transcripts and sets a new standard for gene expression data capacity on...

Delayed minimally invasive cranioplasty reduces operative time.
October 1, 2003... 2003 OCT 1 - (NewsRx.com & NewsRx.net) -- Delayed minimally invasive cranioplasty reduces operative time. "Minimally invasive cranioplasty is presented. Stereolithography is a new technology applied for the manufacture of custom-made...

Genomic strategies for diabetic nephropathy reviewed.
October 1, 2003... 2003 OCT 1 - (NewsRx.com & NewsRx.net) -- Researchers reviewed genomic strategies for diabetic nephropathy in a recent issue of the Journal of the American Society of Nephrology. "Insight into the molecular mechanisms that underlie the...

Accuracy of cytological grading of spindle-cell sarcomas evaluated.
October 1, 2003... 2003 OCT 1 - (NewsRx.com & NewsRx.net) -- Accuracy of cytological grading of spindle-cell sarcomas was evaluated. According to published research from India, "Spindle-cell sarcomas constitute an important component of soft-tissue sarcomas,...

ALT-711 DIAMOND positive trial data presented at European cardiology meeting.
October 1, 2003... 2003 OCT 1 - (NewsRx.com & NewsRx.net) -- Alteon, Inc., (ALT) announced that results from the phase IIa proof-of-concept DIAMOND trial of Alteon's lead compound ALT-711 in diastolic heart failure (DHF) patients were presented at the European...

Patents cover proprietary protein crystallization technology.
October 1, 2003... 2003 OCT 1 - (NewsRx.com & NewsRx.net) -- Altus Biologics, Inc., announced the addition of United States and European patents to its protein crystallization technology portfolio. United States patent 6,359,118 was issued for the invention,...

Program established to pursue research and physician education.
October 1, 2003... 2003 OCT 1 - (NewsRx.com & NewsRx.net) -- Beth Israel Deaconess Medical Center (BIDMC) and Alveolus, Inc., have announced the establishment of a program to pursue research and physician education in the field of interventional pulmonology. ...

Patent granted for SPARC sling system.
October 1, 2003... 2003 OCT 1 - (NewsRx.com & NewsRx.net) -- American Medical Systems (AMMD) announced that the company received a U.S. patent covering the SPARC Sling System for curing female stress urinary incontinence. "We are encouraged that the U.S....

Chronic pain pervasive in all age groups, new study shows.
October 1, 2003... 2003 OCT 1 - (NewsRx.com & NewsRx.net) -- New poll results show that more than half of all Americans (57%) have suffered chronic or recurrent pain in the past year. Surprisingly, younger people (18-34) were only slightly less likely than...

Company launches new high-density CodeLink UniSet mouse bioarray.
October 1, 2003... 2003 OCT 1 - (NewsRx.com & NewsRx.net) -- Amersham Biosciences, the life-sciences business of Amersham (AHM), announced the addition of the CodeLink UniSet Mouse 20K I Bioarray to its CodeLink Expression range. This new high density...

Process helps achieve largest antisense oligonucleotide synthesis scale per run.
October 1, 2003... 2003 OCT 1 - (NewsRx.com & NewsRx.net) -- The life sciences business of Amersham (AHM) announced that Isis Pharmaceuticals recently completed the world's largest antisense oligonucleotide synthesis scale per single run. Isis accomplished...

Phase I trial initiated for new anti-HIV drug candidate AMD070.
October 1, 2003... 2003 OCT 1 - (NewsRx.com & NewsRx.net) -- AnorMED, Inc., (AOM) has initiated enrollment into a phase I trial in healthy volunteers to evaluate the safety of AMD070 for the treatment of HIV infection. AMD070 targets the CXCR4 chemokine...

Progress reported in development of new drug delivery device portfolio.
October 1, 2003... 2003 OCT 1 - (NewsRx.com & NewsRx.net) -- Antares Pharma, Inc., (ANTR) announced that it has completed preliminary clinical testing on several of its new device products, and these devices are now available for licensing for use with specific...

Partial clinical hold on phase III trials of cancer vaccine Oncophage.
October 1, 2003... 2003 OCT 1 - (NewsRx.com & NewsRx.net) -- Antigenics, Inc., (AGEN) announced that it had completed a meeting with the U.S. Food and Drug Administration (FDA) on product characterization issues. Following a discussion of the company's...

Classical antisense PTOs used against key multimodal targets.
October 1, 2003... 2003 OCT 1 - (NewsRx.com & NewsRx.net) -- Antisense Pharma focuses on the drug development for cancer treatment by combining precise selection of key cancer target molecules and DNA based phosphorothioate oligonucleotides (PTO). Positive data...

Alliance with NIH, USARMID targets discovery of therapeutics against SARS.
October 1, 2003... 2003 OCT 1 - (NewsRx.com & NewsRx.net) -- Aphios Corporation has executed a cooperative agreement with the National Institute of Allergy and Infectious Diseases (NIAID), U.S. National Institutes of Health (NIH) and the U.S. Army Medical...

Chemistry deal signed for development of small-molecule compounds.
October 1, 2003... 2003 OCT 1 - (NewsRx.com & NewsRx.net) -- ArQule, Inc., (ARQL) announced that it has entered into a chemistry collaboration with Novartis Institutes for BioMedical Research, Inc., (NIBRI), an affiliate of Novartis AG. As part of this...

Telomeric fusion can underlie chromosome 1p loss in meningioma patients.
October 1, 2003... 2003 OCT 1 - (NewsRx.com & NewsRx.net) -- Telomeric fusion can underlie chromosome 1p loss in meningioma patients. "Characteristic cytogenetic aberrations are found in the various histopathological designations of meningioma," scientists...

Lifeline announces initial inventory commitments.
October 1, 2003... 2003 OCT 1 - (NewsRx.com & NewsRx.net) -- Jim Holmes, CEO of Lifeline BioTechnologies, Inc., (LBTT) announced the issuing of four purchase orders to Arthronet Medical, GmbH, CO KB, a German manufacturer of orthopedic surgical hand instruments...

Reconstruction results by vascularized fibula osteoseptocutaneous flap reviewed.
October 1, 2003... 2003 OCT 1 - (NewsRx.com & NewsRx.net) -- Results of fibular reconstruction by vascularized fibula osteoseptocutaneous flap are evaluated. According to a study from Egypt, "This study included 11 patients with lower limb tumors who had...

Variant Creutzfeldt-Jakob disease does not exhibit hematogenous spread.
October 1, 2003... 2003 OCT 1 - (NewsRx.com & NewsRx.net) -- The neuropathology of human patients with variant Creutzfeldt-Jakob disease does not reflect hematogenous spread of the disease. According to published research from England and the United States,...

CHARM Programme demonstrates benefits of Atacand.
October 1, 2003... 2003 OCT 1 - (NewsRx.com & NewsRx.net) -- Data presented at the European Society of Cardiology (ESC) annual meeting demonstrated that Atacand (candesartan cilexetil) reduces both cardiovascular deaths as well as hospital admissions for heart...

CHARM shows ATACAND reduces risk of cardiovascular death.
October 1, 2003... 2003 OCT 1 - (NewsRx.com & NewsRx.net) -- In a comprehensive trial program with an angiotensin receptor blocker (ARB) for heart failure, AstraZeneca's ATACAND (candesartan cilexetil) has been shown to improve survival in patients with chronic...

Direct thrombin inhibitor may prevent major events following myocardial infarction.
October 1, 2003... 2003 OCT 1 - (NewsRx.com & NewsRx.net) -- Data from a phase II dose-guiding study, ESTEEM, indicate that oral Exanta (ximelagatran), the first in a new class of oral direct thrombin inhibitors (oral DTIs), may provide significant additional...

SPORTIF III study shows potential for Exanta (ximelagatran).
October 1, 2003... 2003 OCT 1 - (NewsRx.com & NewsRx.net) -- Latest data from the full presentation of the SPORTIF III study shows a net clinical benefit for Exanta (ximelagatran), the first in a new class of oral direct thrombin inhibitors (oral DTIs), compared...

Atrix submits eighth ANDA to FDA.
October 1, 2003... 2003 OCT 1 - (NewsRx.com & NewsRx.net) -- Atrix Laboratories, Inc., (ATRX) announced that the company has submitted its eighth Abbreviated New Drug Application (ANDA) to the U.S. Food and Drug Administration (FDA) for approval of a generic...

FDA clears urine test for kidney and cardiovascular diseases.
October 1, 2003... 2003 OCT 1 - (NewsRx.com & NewsRx.net) -- AusAm Biotechnologies, Inc., has received approval from the U.S. Food and Drug Administration for Microalbumin Plus, a diagnostic test for kidney and cardiovascular diseases. Urine testing can...

Biotargeted radiopharmaceuticals being developed based on mTCR technology.
October 1, 2003... 2003 OCT 1 - (NewsRx.com & NewsRx.net) -- Avidex Limited and The Dow Chemical Company will collaborate to create biotargeted radiopharmaceuticals for cancer treatment by applying Dow's technology to Avidex's monoclonal T cell receptors (mTCRs),...

Itax licensed from Abbott Laboratories for $75M.
October 1, 2003... 2003 OCT 1 - (NewsRx.com & NewsRx.net) -- Axcan Pharma, Inc., announced that it has acquired an exclusive license for North America, the European Union (including the United Kingdom, France, Germany, Italy and Spain), and Latin America, from...

Pyrimidinone antibiotics exhibit improved antibacterial spectrum.
October 1, 2003... 2003 OCT 1 - (NewsRx.com & NewsRx.net) -- Pyrimidinone antibiotics exhibit an improved antibacterial spectrum. "We report the synthesis and pharmacological evaluation of new derivatives of the natural dipeptide antibiotic TAN 1057 A,B...

Primary central nervous system lymphoma can have cryoglobulin deposits.
October 1, 2003... 2003 OCT 1 - (NewsRx.com & NewsRx.net) -- Primary CNS lymphoma can have associated cryoglobulins too. "Primary central nervous system lymphomas (PCNSLs) represent malignant non-Hodgkin B-cell lymphomas confined to the central nervous...

Architecture of the herpes simplex virus major capsid protein reported.
October 1, 2003... 2003 OCT 1 - (NewsRx.com & NewsRx.net) -- Scientists have reported the architecture of the herpes simplex virus major capsid protein derived from structural bioinformatics. According to published research from the United States, "The...

The strict-late viral promoter UL38p facilitates herpes simplex virus oncolysis.
October 1, 2003... 2003 OCT 1 - (NewsRx.com & NewsRx.net) -- The strict-late viral promoter UL38p facilitates herpes simplex virus oncolysis. "Confinement of transgene expression to target cells is highly desirable in gene therapy. Current strategies of...

Off-pump coronary surgery is safe and effective.
October 1, 2003... 2003 OCT 1 - (NewsRx.com & NewsRx.net) -- Off-pump coronary surgery is safe and effective. According to recent research from Argentina, "The learning curve in off pump surgery must be followed due to the fact that beating heart coronary...

Companies count on proper training to avoid regulatory notices.
October 1, 2003... 2003 OCT 1 - (NewsRx.com & NewsRx.net) -- In the middle of increased regulation and U.S. Food and Drug Administration (FDA) scrutiny of manufacturing and quality control processes, global business leaders avoid regulatory notices by creating...

Centrex CEO named to board of directors at biotech company.
October 1, 2003... 2003 OCT 1 - (NewsRx.com & NewsRx.net) -- Centrex, Inc., (CNEX) and Bio-Defense Research Group, Inc., (BDRGI) announced that they have entered into a strategic alliance to explore the joint applications, development, and marketing of their...

Research, supply, comarketing agreement signed for assay development.
October 1, 2003... 2003 OCT 1 - (NewsRx.com & NewsRx.net) -- Bio-Rad Laboratories, Inc., (BIO; BIO.B) announced that it has entered into a research, supply, and comarketing agreement with Cell Signaling Technology, Inc., (CST). Under this exclusive...

Reference lab reports substantial gains on record operating results.
October 1, 2003... 2003 OCT 1 - (NewsRx.com & NewsRx.net) -- Bio-Reference Laboratories, Inc., (BRLI) released its third quarter, fiscal year 2003 earnings for the 3 months ending July 31. The company posted record pre-tax net income of $3,000,464 on record...

Animal studies demonstrate normalization of carbohydrate storage in brain tissue.
October 1, 2003... 2003 OCT 1 - (NewsRx.com & NewsRx.net) -- BioMarin Pharmaceutical, Inc., (BMRN) announced results from studies indicating that intrathecal injection of recombinant human alpha-L-iduronidase (rhIDU) can reduce carbohydrate storage in brain...

Tissue repair biotech company closes private placement.
October 1, 2003... 2003 OCT 1 - (NewsRx.com & NewsRx.net) -- BioSyntech (BSYI) confirmed that a previously announced private placement has been closed for an amount of $633,000, representing the issuance of 633 units at a price of $1000 per unit. Each unit...

Oncology company's common stock to be listed on American Stock Exchange.
October 1, 2003... 2003 OCT 1 - (NewsRx.com & NewsRx.net) -- Bioenvision, Inc., (BIOV) announced that its common stock has been approved for listing on the American Stock Exchange. Effective September 8, 2003, Bioenvision's common stock began trading on the...

SEC guidance issued on device company's revenue recognition question.
October 1, 2003... 2003 OCT 1 - (NewsRx.com & NewsRx.net) -- Biolase Technology, Inc., (BLTIE) announced that, based upon guidance from the U.S. Securities and Exchange Commission received on August 28, the company will amend previously issued financial...

Data from Theratope vaccine trial to be presented at breast cancer symposium.
October 1, 2003... 2003 OCT 1 - (NewsRx.com & NewsRx.net) -- Biomira, Inc., (BIOM, BRA) announced that data from the final analysis of its Theratope vaccine phase III clinical trial in metastatic breast cancer will be presented at the 26th Annual San Antonio...

Phase I testing of HIV microbicide initiated.
October 1, 2003... 2003 OCT 1 - (NewsRx.com & NewsRx.net) -- Biosyn, Inc., announced that enrollment has been initiated for a phase I clinical trial for the investigational drug candidate, UC-781, as a microbicide for the prevention of sexually transmitted HIV....

Hayden named chief financial officer at pharmaceutical company.
October 1, 2003... 2003 OCT 1 - (NewsRx.com & NewsRx.net) -- Bone Care International, Inc., (BCII) announced that Brian J. Hayden has been appointed to the position of chief financial officer, responsible for finance and investor relations, effective October 1,...

Leptin peptide is potent inhibitor of leptin receptor function.
October 1, 2003... 2003 OCT 1 - (NewsRx.com & NewsRx.net) -- A peptide derived from the human leptin molecule is a potent inhibitor of the leptin receptor function in rabbit endometrial cells. According to recent research from the United States, "In this...

Class of molecules stimulate optic nerve regeneration.
October 1, 2003... 2003 OCT 1 - (NewsRx.com & NewsRx.net) -- Boston Life Sciences, Inc., (BLSI), a development stage biotechnology company, announced that scientists at Boston Children's Hospital and BLSI have identified specific carbohydrates (sugars) capable of...

Expression of anti-colorectal cancer polyclonal antibody library reported.
October 1, 2003... 2003 OCT 1 - (NewsRx.com & NewsRx.net) -- Researchers have reported the expression of a prototypic anti-colorectal cancer polyclonal antibody library in mammalian cells. "We describe the production of a prototypic polyclonal antibody...

Gene expression differs in lung adenocarcinomas of smokers and nonsmokers.
October 1, 2003... 2003 OCT 1 - (NewsRx.com & NewsRx.net) -- Gene expression differs in lung adenocarcinomas of smokers and nonsmokers. "Adenocarcinoma (AC) has become the most frequent type of lung cancer in men and women and is the major form of lung cancer...

Link to cholesterol drugs disputed.
October 1, 2003... 2003 OCT 1 - (NewsRx.com & NewsRx.net) -- Widely used cholesterol-lowering drugs do not appear to raise the risk of suicide, and might even reduce depression, according to researchers trying to clarify conflicting earlier studies. Some...

Polymer-coated stents offer a way to delivery gene therapy to immune cells.
October 1, 2003... 2003 OCT 1 - (NewsRx.com & NewsRx.net) -- Polymer-coated stents offer a way to delivery gene therapy to immune cells. According to a study from the United States, "metallic stents coated with a polyurethane emulsion containing plasmid DNA...

Consumers may be misled by Internet claims on health benefits of herbal products.
October 1, 2003... 2003 OCT 1 - (NewsRx.com & NewsRx.net) -- Herbal products sold on the Internet may have misleading claims that they can treat, prevent, diagnose, or cure specific diseases despite regulations prohibiting these types of statements, according to...

Clot-busters - do they work for all?
October 1, 2003... 2003 OCT 1 - (NewsRx.com & NewsRx.net) -- Aspirin is given to patients at high risk of suffering an acute myocardial infarction (AMI), but researchers in Denmark have shown that in one-third of patients actually suffering an AMI no...

Inpharmatica secures ADME agreement.
October 1, 2003... 2003 OCT 1 - (NewsRx.com & NewsRx.net) -- Inpharmatica, Ltd., a selective drug discovery company, announced that it has entered into a 2-year agreement with British Biotech, for the provision of ADME (absorption, distribution, metabolism, and...

Liberty Health Care contracts with Brocade to develop storage area network.
October 1, 2003... 2003 OCT 1 - (NewsRx.com & NewsRx.net) -- Brocade Communications Systems, Inc., (BRCD), a provider of infrastructure for storage area networks (SANs), announced that Liberty Health Care Group, Inc., (Liberty), a direct-to-home provider of...

PET scans show cigarette smoke affects peripheral organs.
October 1, 2003... 2003 OCT 1 - (NewsRx.com & NewsRx.net) -- It is well known that smoking cigarettes can directly and often fatally damage the lungs. But new research shows that cigarette smoke also decreases levels of a critical enzyme called monoamine oxidase...

Novel Autoflex TOF/TOF system introduced for proteomics research.
October 1, 2003... 2003 OCT 1 - (NewsRx.com & NewsRx.net) -- Bruker Daltonics, Inc., a subsidiary of Bruker BioSciences Corporation (BRKR), introduced the autoflex TOF/TOF system, a compact high-performance MALDI-TOF/TOF mass spectrometer. This first...

Biotech wilts in August, but rally isn't over.
October 1, 2003... 2003 OCT 1 - (NewsRx.com & NewsRx.net) -- Although the economy held its own in August, news of a federal budget deficit of $480 billion hit the headlines and cast a shadow on Wall Street. The DJIA gained just 2% in August and NASDAQ's value...

TCR signal strength controls GATA-3 levels, regulating T-cell differentiation.
October 1, 2003... 2003 OCT 1 - (NewsRx.com & NewsRx.net) -- The strength of TCR signal induces differential expression of GATA-3, it in turn regulates CD4/CD8 differentiation. "GATA-3 is expressed at higher levels in CD4 than in CD8 SP thymocytes. Here we...

The main advantage of laparascopic repair seems to be improved patient comfort.
October 1, 2003... 2003 OCT 1 - (NewsRx.com & NewsRx.net) -- The main advantage of laparascopic repair seems to be improved patient comfort. "The main advantage of laparoscopic repair seems to be improved patient comfort. A meta-analysis of randomized studies...

Stavudine treatment, low CD4 cell counts are hypothyroidism risk factors in HIV patients.
October 1, 2003... 2003 OCT 1 - (NewsRx.com & NewsRx.net) -- Stavudine treatment and immune suppression increase the risk of thyroid hormone deficiency in HIV patients. Scientists in France conducted a study "to determine the prevalence of and risk factors...

Toxoplasma gondii ELISA can give false-positive IgM due to sphingolipids.
October 1, 2003... 2003 OCT 1 - (NewsRx.com & NewsRx.net) -- Toxoplasma gondii ELISA can have unspecific IgM reactivity that corresponds with sphingolipids or ceramides found in pathogen, but not due to infection, in pregnant or grafted patients. "During a...

Agreement signed for financing of PET equipment.
October 1, 2003... 2003 OCT 1 - (NewsRx.com & NewsRx.net) -- CTI Molecular Imaging, Inc., (CTMI), a provider of positron emission tomography (PET) equipment, molecular probes and services, and De Lage Landen Financial Services, Inc., of Wayne, Pennsylvania,...

Product license agreement signed with Micromet for MT201.
October 1, 2003... 2003 OCT 1 - (NewsRx.com & NewsRx.net) -- Cambridge Antibody Technology Group plc (CATG) announced the grant of a non-exclusive patent license to Micromet AG for the development and commercialization of its proprietary human therapeutic...

Innovations in liver surgery transplantation from living donors reviewed.
October 1, 2003... 2003 OCT 1 - (NewsRx.com & NewsRx.net) -- Innovations in liver surgery through transplantation from living donors are reviewed. "Living-donor liver transplantation was introduced into clinical practice in the early 1990s. At first the...

Deal signed to share development of West Nile virus hyperimmune globulin.
October 1, 2003... 2003 OCT 1 - (NewsRx.com & NewsRx.net) -- Cangene has entered a collaborative research and development agreement with Acambis plc to develop and manufacture a hyperimmune globulin for treating and preventing infection by West Nile virus (West...

The anterolateral thigh flap is used for reconstruction of intraoral defects.
October 1, 2003... 2003 OCT 1 - (NewsRx.com & NewsRx.net) -- The anterolateral thigh flap is used for reconstruction of intraoral defects. "The anterolateral thigh (ALT) flap has achieved popularity recently for free-flap reconstruction of intraoral defects...

Government agencies select supplier of automated external defibrillators.
October 1, 2003... 2003 OCT 1 - (NewsRx.com & NewsRx.net) -- Cardiac Science, Inc., (DFIB), a manufacturer of automated public access defibrillators (AEDs), announced that it has been selected by three government agencies, including the U.S. Postal Inspection...

New center will examine social and economic implications.
October 1, 2003... 2003 OCT 1 - (NewsRx.com & NewsRx.net) -- A major new research center will help society to understand the economic and social impact of new genetic technologies. CESAGen, the Center for Economic and Social Aspects of Genomics, was...

Cardiology device maker reports sale of stock.
October 1, 2003... 2003 OCT 1 - (NewsRx.com & NewsRx.net) -- CardioDynamics (CDIC) announced that 500,000 shares of the company's stock were purchased from the Allen E. Paulson Trust and 250,000 shares owned personally by the Trustee, J. Michael Paulson, by an...

Medical device maker projects 621% increase in revenues.
October 1, 2003... 2003 OCT 1 - (NewsRx.com & NewsRx.net) -- CardioTech International, Inc., (CTE) announced that as a service to investors, the company is providing revenue guidance for the second quarter of FY 2004, ending September 30, 2003. The company...